Literature DB >> 7564056

[The evaluation of interleukin-8 (IL-8) and tumor necrosis factor-alpha (TNF-alpha) level in peripheral blood of patients with active pulmonary tuberculosis].

M Nakaya1, T Yoneda, M Yoshikawa, K Tsukaguchi, T Tokuyama, A Fu, Y Okamoto, K Fukuoka, C Yamamoto, A Fukuoka.   

Abstract

We investigated the serum level of IL-8 and TNF-alpha using ELISA in 16 patients with active pulmonary tuberculosis before administration of antituberculous drugs and in age-, smoking habit-matched 20 healthy controls. The mean level of serum IL-8 in patients with active pulmonary tuberculosis was significantly higher than that in healthy controls (P < 0.001). The mean level of serum TNF-alpha in tuberculosis patients was also high, while TNF-alpha was not detectable in the sera of healthy controls. We also examined the relationship between clinical pictures mainly defined by radiographic findings and the serum levels of IL-8 and TNF-alpha. The serum IL-8 level of 9 patients with tuberculous cavity is significantly higher than that of 7 patients without cavity. (P < 0.05) We classified the patients with cavities into two subgroups according to the radiographic classification of the Japanese Society of Tuberculosis. Four patients with advanced lesions on chest X-ray showed higher serum IL-8 level than 5 patients with moderate lesions (P < 0.05). On the other hand, there was no correlation between serum TNF-alpha level and radiographic findings. These results suggest that IL-8 appears to be involved in the formation of tuberculous cavitary lesion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564056

Source DB:  PubMed          Journal:  Kekkaku        ISSN: 0022-9776


  6 in total

1.  A study of serum malondialdehyde and cytokine in tuberculosis patients.

Authors:  Rashmi Kulkarni; Ajit Deshpande; Ravi Saxena; Kiran Saxena
Journal:  J Clin Diagn Res       Date:  2013-10-05

2.  The production of tumour necrosis factor-alpha is decreased in peripheral blood mononuclear cells from multidrug-resistant tuberculosis patients following stimulation with the 30-kDa antigen of Mycobacterium tuberculosis.

Authors:  J-S Lee; C-H Song; J-H Lim; H-J Kim; J-K Park; T-H Paik; C-H Kim; S-J Kong; M-H Shon; S-S Jung; E-K Jo
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

3.  Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG.

Authors:  R Al-Attiyah; A S Mustafa
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

4.  Changes in serum cytokine levels in active tuberculosis with treatment.

Authors:  Figen Deveci; H Handan Akbulut; Teyfik Turgut; M Hamdi Muz
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

5.  Evaluation of TNF-α, IL-10 and IL-6 Cytokine Production and Their Correlation with Genotype Variants amongst Tuberculosis Patients and Their Household Contacts.

Authors:  Lavanya Joshi; Meenakshi Ponnana; Ramya Sivangala; Lakshmi Kiran Chelluri; Prathiba Nallari; Sitaramaraju Penmetsa; Vijayalakshmi Valluri; Sumanlatha Gaddam
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

6.  Binding of CXCL8/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune Response.

Authors:  Agnieszka Krupa; Marek Fol; Bozena R Dziadek; Ewa Kepka; Dominika Wojciechowska; Anna Brzostek; Agnieszka Torzewska; Jaroslaw Dziadek; Robert P Baughman; David Griffith; Anna K Kurdowska
Journal:  Mediators Inflamm       Date:  2015-08-02       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.